Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Effect of GVHD prophylaxis on renal function and survival outcomes in allogeneic hematopoietic cell transplant patients with pre-existing renal impairment

Blood (2025) 146 (Supplement 1): 7764.

https://doi.org/10.1182/blood-2025-7764

Published: 2025

Journal Articles

Feasibility and safety of accelerated glofitamab step-up in rapidly progressive relapsed/refractory diffuse large B-cell lymphoma: A real-world single center experience

Fnu Amisha, Syeda Saba Kareem, Kiranpreet Kaur, Biwei Cao, Samuel Reynolds, Yumeng Zhang, Celeste Bello, Leidy Isenalumhe, Sameh Gaballa, Omar Alexis Castaneda Puglianini, Aleksandr Lazaryan, Javier Pinilla-Ibarz, Lubomir Sokol, Bijal Shah, Frederick Locke, Julio Chavez, Michael Jain

Blood (2025) 146 (Supplement 1): 5512.

https://doi.org/10.1182/blood-2025-5512

Published: 2025

Journal Articles

Outcomes of elderly (≥ 70) Acute Myeloid Leukemia (AML) patients receiving continued hypomethylating agent/venetoclax (HMA/VEN) versus allogeneic hematopoietic cell transplantation (HCT)

Blood (2025) 146 (Supplement 1): 4300.

https://doi.org/10.1182/blood-2025-4300

Published: 2025

Journal Articles

Persistent racial disparities in Sézary syndrome outcomes despite use of modern therapies: A single-center analysis

Lalith Roopesh, Kimberly Ward, Fnu Amisha, Shannen Whiddon, Janice Bennett, Hien Liu, Lewis Glass, Lubomir Sokol, Yumeng Zhang

Blood (2025) 146 (Supplement 1): 5427.

https://doi.org/10.1182/blood-2025-5427

Published: 2025

Journal Articles

Cytopenias and infectious complications following CD19-directed CAR-T cell therapy in patients with B-ALL: A single-center retrospective analysis

Kriti Gera, Fnu Amisha, Filip Ionescu, Jasmine Nadayil, Vaishnavi Jayakumar, Corey Tesdahl, Jessica Shostak, Wenyi Fan, Leidy Isenalumhe, Farhad Khimani, Frederick Locke, Michael Jain, Bijal Shah, Rawan Faramand

Blood (2025) 146 (Supplement 1): 1580.

https://doi.org/10.1182/blood-2025-1580

Published: 2025

Journal Articles

Clinical and genomic landscape of STAT5B mutations in lymphoid and myeloid malignancies

Fnu Amisha, Jessica Shostak, Wenyi Fan, Onyee Chan, Rory Shallis, Zhuoer Xie, Alison Walker, Sameh Gaballa, Javier Pinilla-Ibarz, Eric Padron, David Sallman, Bijal Shah, Julio Chavez, Rami Komrokji, Jeffrey Lancet, Mohammad Hussaini, Yumeng Zhang, Todd Knepper, Andrew Kuykendall

Blood (2025) 146 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2025-3531

Published: 2025

Journal Articles

Discontinuation of targeted therapy in histiocytic neoplasms with durable response: A multicenter retrospective study

XI Yang, Haadi Ali, Dana Bossert, Carla Isabel Borre, Brinda H Shukla, Jacquelyn Fitzgerald, Mikaela McDonough, Corbin Wright, Fnu Amisha, Samuel Reynolds, Eric Jacobsen, Eli Diamond, Gaurav Goyal, Jithma Abeykoon, Ronald Go, Asra Ahmed

Blood (2025) 146 (Supplement 1): 726.

https://doi.org/10.1182/blood-2025-726

Published: 2025

Journal Articles

Refined elderly comorbidity index is highly predictive of post-transplant survival in older adults with Acute Myeloid Leukemia and myelodysplastic syndrome

Blood (2025) 146 (Supplement 1): 6076.

https://doi.org/10.1182/blood-2025-6076

Published: 2025

Journal Articles

Patterns of Progression and Outcomes in Multiple Myeloma after Anti-BCMA CAR T-Cell Therapy

Ziad Abuhelwa, Fnu Amisha, Wenyi Fan, Gabriel De Avila, Doris K. Hansen, Ariel F. Grajales-Cruz, Brandon Blue, Omar Castaneda, Hien Liu, Ciara Louise Freeman, Taiga Nishihori, Frederick Locke, Kenneth H. Shain, Rachid Baz, Melissa Alsina

Blood (2024) 144 (Supplement 1): 4692.

https://doi.org/10.1182/blood-2024-204270

Published: 2024

Journal Articles

Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis

Blood (2024) 144 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2024-208229

Published: 2024

Journal Articles

Predictive Markers for Outcomes after Disease Progression Post BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Fnu Amisha, Ziad Abuhelwa, Wenyi Fan, Doris K. Hansen, Omar Castaneda, Ciara Louise Freeman, Hien Liu, Frederick Locke, Taiga Nishihori, Ariel Grajales-Cruz, Brandon Blue, Kenneth H. Shain, Melissa Alsina, Rachid Baz

Blood (2024) 144 (Supplement 1): 2004.

https://doi.org/10.1182/blood-2024-211822

Published: 2024

Journal Articles

Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms

Tyler Fugere, Brad Fugere, Fnu Amisha, Jim Zhongning Chen, Akash Mukherjee, Mamatha Gaddam, Muthu Veeraputhiran, Cesar Giancarlo Gentille Sanchez

Blood (2023) 142 (Supplement 1): 5346.

https://doi.org/10.1182/blood-2023-187700

Published: 2023

Journal Articles

Leveraging Deep Neural Networks to Predict Time to Event in Pediatric B-Lymphoblastic Leukemia

Jim Zhongning Chen, Alan Baltz, Tyler Fugere, Emily Noel Sanders, Fnu Amisha, Cesar Giancarlo Gentille Sanchez, Maria Alejandra Pereda

Blood (2023) 142 (Supplement 1): 4355.

https://doi.org/10.1182/blood-2023-188277

Published: 2023

Journal Articles

Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes

Fnu Amisha, Manojna Konda, Paras Malik, Tyler Fugere, Arya Mariam Roy, Akash Mukherjee

Blood (2021) 138 (Supplement 1): 1629.

https://doi.org/10.1182/blood-2021-149170

Published: 2021

Journal Articles

Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study

Fnu Amisha, Paras Malik, Manojna Konda, Sunilkumar Kakadia, Tyler Fugere, Akash Mukherjee

Blood (2021) 138 (Supplement 1): 4537.

https://doi.org/10.1182/blood-2021-154381

Published: 2021

Journal Articles

Clinical Outcome of Refractory Lymphoma Patients with Non Response to Chimeric Antigen Receptor T Cell Therapy

Fnu Amisha, Sunilkumar Kakadia, Akash Mukherjee

Blood (2021) 138 (Supplement 1): 4823.

https://doi.org/10.1182/blood-2021-154356

Published: 2021

Journal Articles

Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review

Fnu Amisha, Manojna Konda, Paras Malik, Arya Mariam Roy, Appalanaidu Sasapu

Blood (2021) 138 (Supplement 1): 3159.

https://doi.org/10.1182/blood-2021-145076

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Effect of GVHD prophylaxis on renal function and survival outcomes in allogeneic hematopoietic cell transplant patients with pre-existing renal impairment

Feasibility and safety of accelerated glofitamab step-up in rapidly progressive relapsed/refractory diffuse large B-cell lymphoma: A real-world single center experience

Outcomes of elderly (≥ 70) Acute Myeloid Leukemia (AML) patients receiving continued hypomethylating agent/venetoclax (HMA/VEN) versus allogeneic hematopoietic cell transplantation (HCT)

Persistent racial disparities in Sézary syndrome outcomes despite use of modern therapies: A single-center analysis

Cytopenias and infectious complications following CD19-directed CAR-T cell therapy in patients with B-ALL: A single-center retrospective analysis

Clinical and genomic landscape of STAT5B mutations in lymphoid and myeloid malignancies

Discontinuation of targeted therapy in histiocytic neoplasms with durable response: A multicenter retrospective study

Refined elderly comorbidity index is highly predictive of post-transplant survival in older adults with Acute Myeloid Leukemia and myelodysplastic syndrome

Patterns of Progression and Outcomes in Multiple Myeloma after Anti-BCMA CAR T-Cell Therapy

Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis

Predictive Markers for Outcomes after Disease Progression Post BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms

Leveraging Deep Neural Networks to Predict Time to Event in Pediatric B-Lymphoblastic Leukemia

Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes

Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study

Clinical Outcome of Refractory Lymphoma Patients with Non Response to Chimeric Antigen Receptor T Cell Therapy

Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only